Jan Trka
Dr. Jan Trka is currently a Professor of Medical Genetics and the Head of the Laboratory Center of Department of Pediatric Hematology and Oncology of 2nd Faculty of Medicine, Charles University and University Hospital in Prague – Motol, Czech Republic. He obtained his MD degree in Medicine and PhD in Molecular biology from Charles University in Prague, and spent several years on PhD and postdoc positions in research institutes in Austria and the UK. He has founded and leads the Childhood Leukemia Investigation Prague (CLIP) group. He is an active member of the International Members Committee and the Committee on Communication of the American Society of Hematology (ASH) and the head of the Biology and Diagnosis Committee of the International BFM Study Group (I-BFM SG). He has published over 80 peer-reviewed articles, has received a number of grants and scientific awards and is a reviewer for international journals and grant agencies. He is devoted to the childhood acute leukemia research with special interests in leukemic clone origin and development and minimal residual disease detection.
State-of-the-Art lecture
Dr. Jan Trka is currently a Professor of Medical Genetics and the Head of the Laboratory Center of Department of Pediatric Hematology and Oncology of 2nd Faculty of Medicine, Charles University and University Hospital in Prague – Motol, Czech Republic. He obtained his MD degree in Medicine and PhD in Molecular biology from Charles University in Prague, and spent several years on PhD and postdoc positions in research institutes in Austria and the UK. He has founded and leads the Childhood Leukemia Investigation Prague (CLIP) group. He is an active member of the International Members Committee and the Committee on Communication of the American Society of Hematology (ASH) and the head of the Biology and Diagnosis Committee of the International BFM Study Group (I-BFM SG). He has published over 80 peer-reviewed articles, has received a number of grants and scientific awards and is a reviewer for international journals and grant agencies. He is devoted to the childhood acute leukemia research with special interests in leukemic clone origin and development and minimal residual disease detection.
Panel discussion /All speakers
Panel discussion /All speakers for Panel discussion /All speakers
